OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A comprehensive review of immune checkpoint inhibitors for cancer treatment
Md Aslam Hossain
International Immunopharmacology (2024) Vol. 143, pp. 113365-113365
Closed Access | Times Cited: 7
Md Aslam Hossain
International Immunopharmacology (2024) Vol. 143, pp. 113365-113365
Closed Access | Times Cited: 7
Showing 7 citing articles:
Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies
Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli
Cancers (2025) Vol. 17, Iss. 5, pp. 906-906
Open Access | Times Cited: 1
Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli
Cancers (2025) Vol. 17, Iss. 5, pp. 906-906
Open Access | Times Cited: 1
Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and bulk RNA-seq
Yulin Shi, Yang Yu, J. Zhao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Yulin Shi, Yang Yu, J. Zhao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Cardiac Magnetic Resonance Imaging in Immune Checkpoint Inhibitor–Related Myocarditis
Matthew Hammer, Maciej Tysarowski, Cristina Fuss, et al.
Echocardiography (2025) Vol. 42, Iss. 3
Closed Access
Matthew Hammer, Maciej Tysarowski, Cristina Fuss, et al.
Echocardiography (2025) Vol. 42, Iss. 3
Closed Access
Recent advances in oncolytic virus combined immunotherapy in tumor treatment
Xiaoli Zhou, Shunfeng Hu, Xin Wang
Genes & Diseases (2025), pp. 101599-101599
Open Access
Xiaoli Zhou, Shunfeng Hu, Xin Wang
Genes & Diseases (2025), pp. 101599-101599
Open Access
The role of B2M in cancer immunotherapy resistance: function, resistance mechanism, and reversal strategies
Xiaowen Han, Jiayi Zhang, Weidong Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Xiaowen Han, Jiayi Zhang, Weidong Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Salem Baldi, Mohammed Alnaggar, Maged AL-Mogahed, et al.
The EPMA Journal (2025)
Closed Access
Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database
Huiping Zhang, Zhuo Zhou, Juan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Huiping Zhang, Zhuo Zhou, Juan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A newly constructed STC2/FPR1 dual genes signature works as a prognosis risk indicator with implication in the macrophages dominated and TIM-3 checkpoint related osteosarcoma immune landscape
Wenxia Ma, Lei Miao, Siying Liu, et al.
Research Square (Research Square) (2024)
Closed Access
Wenxia Ma, Lei Miao, Siying Liu, et al.
Research Square (Research Square) (2024)
Closed Access
